[
  {
    "reportName": "Unaudited Condensed Balance Sheet",
    "data": {
      "header": "Unaudited Condensed Balance Sheet - USD $ in Thousands",
      "period": "Sep. 30, 2022",
      "data": {
        "Restricted cash and restricted cash equivalents": 326274,
        "Investments in available-for-sale securities (amortized cost of $204,359 and $195,796, respectively)": 195133,
        "Loans, less allowance for credit losses on loans": 11204403,
        "Servicing rights": 168438,
        "Securitization investments": 261672,
        "Equity method investments": 0,
        "Property, equipment and software": 164421,
        "Goodwill": 1622951,
        "Intangible assets": 456771,
        "Operating lease right-of-use assets": 100411,
        "Other assets, less allowance for credit losses of $1,791 and $2,292, respectively": 399270,
        "Total assets": 15834903,
        "Noninterest-bearing deposits": 89761,
        "Interest-bearing deposits": 4941869,
        "Total deposits": 5031630,
        "Accounts payable, accruals and other liabilities": 565910,
        "Operating lease liabilities": 121729,
        "Debt": 4568523,
        "Residual interests classified as debt": 45734,
        "Total liabilities": 10333526,
        "Redeemable preferred stock, $0.00 par value: 100,000,000 shares authorized; 3,234,000 shares issued and outstanding as of September 30, 2022 and December 31, 2021": 320374,
        "Common stock": 92,
        "Additional paid-in capital": 6654026,
        "Total permanent equity": 5181003
      }
    },
    "periodOfReport": "2022-09-30",
    "dateFiled": "2022-11-09",
    "formType": "10-Q",
    "quarter": "Q3"
  },
  {
    "reportName": "Unaudited Condensed Statement of Operations and Comprehensive Loss",
    "data": {
      "header": "Unaudited Condensed Statement of Operations and Comprehensive Loss - USD $ in Thousands",
      "period": "3 Months Ended",
      "data": {
        "Securitizations": 2633,
        "Related party notes": 0,
        "Other": 21879,
        "Total interest income": 198039,
        "Securitizations and warehouses": 20653,
        "Deposits": 14149,
        "Corporate borrowings": 5270,
        "Total interest expense": 40189,
        "Net interest income": 157850,
        "Loan origination and sales": 163697,
        "Servicing": 7296,
        "Technology products and solutions": 82035,
        "Total noninterest income": 266135,
        "Total net revenue (loss)": 423985,
        "Technology and product development": 110702,
        "Sales and marketing": 162129,
        "Cost of operations": 83083,
        "General and administrative": 126199,
        "Provision for credit losses": 16323,
        "Total noninterest expense": 498436,
        "Income tax benefit (expense)": 242,
        "Foreign currency translation adjustments, net": 325,
        "Total other comprehensive income (loss)": 54,
        "Weighted average common stock outstanding - basic (in shares)": 916762973,
        "Weighted average common stock outstanding - diluted (in shares)": 916762973
      }
    },
    "periodOfReport": "2022-09-30",
    "dateFiled": "2022-11-09",
    "formType": "10-Q",
    "quarter": "Q3"
  },
  {
    "reportName": "Unaudited Condensed Statement of Cash Flow",
    "data": {
      "header": "Unaudited Condensed Statement of Cash Flow - USD $ in Thousands",
      "period": "9 Months Ended",
      "data": {
        "Share-based compensation expense": 235018,
        "Depreciation and amortization": 109007,
        "Deferred debt issuance and discount expense": 12106,
        "Provision for credit losses": 39387,
        "Deferred income taxes": 699,
        "Fair value changes in residual interests classified as debt": 7078,
        "Fair value changes in securitization investments": 13256,
        "Fair value changes in warrant liabilities": 0,
        "Other": 11635,
        "Proceeds from sales and repayments of loans": 6654289,
        "Other changes in loans": 10566,
        "Related party notes receivable interest income": 0,
        "Accounts payable, accruals and other liabilities": 28265,
        "Proceeds from sales of available-for-sale investments": 23497,
        "Proceeds from maturities and paydowns of available-for-sale investments": 14327,
        "Changes in loans, net": 0,
        "Proceeds from securitization investments": 99760,
        "Purchases of non-securitization investments": 0,
        "Proceeds from non-securitization investments": 0,
        "Acquisition of businesses, net of cash acquired": 58540,
        "Proceeds from repayment of related party notes receivable": 0,
        "Net cash provided by (used in) investing activities": 79536,
        "Proceeds from debt issuances": 7861804,
        "Net change in deposits": 4859240,
        "Proceeds from stock option exercises": 2489,
        "Purchases of common stock": 0,
        "Redemptions of redeemable common and preferred stock": 0,
        "Proceeds from Business Combination and PIPE Investment": 0,
        "Payment of costs directly attributable to the issuance of common stock in connection with Business Combination and PIPE Investment": 0,
        "Net cash provided by (used in) financing activities": 5384714,
        "Effect of exchange rates on cash and cash equivalents": 231,
        "Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents": 492996,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period": 768437,
        "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period": 1261433,
        "Cash and cash equivalents": 935159,
        "Restricted cash and restricted cash equivalents": 326274,
        "Total cash, cash equivalents, restricted cash and restricted cash equivalents": 1261433,
        "Issuance of common stock in acquisition": 873377,
        "Vested awards assumed in acquisition": 2855,
        "Loans received in acquisition": 84485,
        "Debt assumed in acquisition": 2000,
        "Deposits assumed in acquisition": 158016,
        "Deposits credited but not yet received in cash": 14374,
        "Available-for-sale securities received in acquisition": 10014,
        "Property, equipment and software received in acquisition": 3192,
        "Non-cash loan reduction": 1386,
        "Share-based compensation capitalized related to internally-developed software": 16177,
        "Redeemable preferred stock dividends accrued but unpaid": 10189,
        "Non-cash property, equipment, software and intangible asset additions": 0,
        "Deferred debt issuance costs accrued but unpaid": 0,
        "Securitization investments acquired via loan transfers": 0,
        "Available-for-sale investment securities purchased but unpaid": 0,
        "Costs directly attributable to the issuance of common stock paid in 2020": 0,
        "Reduction to temporary equity associated with purchase price adjustments": 0,
        "Warrant liabilities recognized in conjunction with the Business Combination": 0,
        "Series H warrant liabilities conversion to common stock warrants": 0
      }
    },
    "periodOfReport": "2022-09-30",
    "dateFiled": "2022-11-09",
    "formType": "10-Q",
    "quarter": "Q3"
  }
]